Anixa Biosciences Director Lewis H. Titterton Jr acquires $9,172 of common shares
ANIX•Director buys additional common shares
- Anixa Biosciences director Lewis H. Titterton Jr. bought 2,797 common shares at USD 3.28 each.
- His direct beneficial ownership rose to 974,967 common shares.
